Mesothelioma Clinical Trials & Research

Because we’re involved in research related to all aspects of care, Memorial Sloan Kettering is often the first to be aware of the latest scientific discoveries and medical advances for mesothelioma. We’re constantly testing new ways to fight mesothelioma. Our patients have access to clinical trials of new treatment options that are not available in most other hospitals.

As a mesothelioma patient at Memorial Sloan Kettering — regardless of the stage of your disease — there will likely be a clinical trial option for you.

These research studies evaluate the safety and effectiveness of new ways to diagnose and treat mesothelioma. They can also give your treatment team information about your current plan of care. Promising approaches that we’ve looked at so far include tumor vaccines, antibody therapies, T cell–based treatments, molecularly targeted medications, and the use of anticancer viruses.

Here you can find a continually updated listing of MSK’s current clinical trials for mesothelioma. To learn more about a study, choose from the list below.

Reset

11 Clinical Trials found